Trevena Advances NDA Resubmission Activities for Oliceridine

Aug 28, 2019 4:01pm EDT

Trevena Reports Second Quarter 2019 Results

Aug 07, 2019 7:00am EDT

Trevena to Report Second Quarter 2019 Results on August 7, 2019

Jul 31, 2019 7:00am EDT

Trevena Appoints Barry Shin as Chief Financial Officer

Jun 27, 2019 7:00am EDT

Trevena Announces Publication of APOLLO-2 Results in Pain Practice

Jun 24, 2019 7:00am EDT

Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine

Jun 20, 2019 7:00am EDT

Trevena to Participate in Upcoming Conferences in June 2019

May 29, 2019 4:01pm EDT

Trevena Reports First Quarter 2019 Results

May 10, 2019 7:00am EDT

Trevena Reports Fourth Quarter and Full Year 2018 Results

Mar 13, 2019 7:00am EDT

Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain

Mar 11, 2019 3:00am EDT